CKD-828 Primary Hypertension Trial(Dose-selection)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 430 participants.
Also called NCT01128322
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 430 participants
- Registry
-
NCT01128322
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01128322. Randomized; triple masking; primary purpose treatment. Start 2010-07 (registry gives no type); primary completion 2011-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CKD-828 Primary Hypertension Trial(Dose-selection)
- Condition
- Hypertension
- Intervention (Drug)
- S-Amlodipine, Telmisartan
- Intervention (Drug)
- S-Amlodipine
- Intervention (Drug)
- Telmisartan
- Intervention (Drug)
- Placebo
- Lead sponsor
- Chong Kun Dang Pharmaceutical
Record details
- Record id
cardio:ct-nct01128322- Content hash
082e3fe36428f5ef0729baa98b9ee1617ee4474ed02cffcde9d716ad66ba21df